TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.81
0.00 (0.00%)
At close: Aug 15, 2025, 2:44 PM
TScan Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.88M | 4.42M | 2.82M | 9.36M | 12.2M | 14.81M | 21.05M | 13.84M | 13.31M | 14.22M | 10.44M | 13.29M | 12.34M | 11.13M | 10.14M | 8.08M | 5.96M | 3.11M |
Cost of Revenue | 1.74M | 2.85M | 4.11M | 4.68M | 4.94M | 5.12M | 5.36M | 5.57M | 4.28M | 4.19M | 3.89M | 3.54M | 17.75M | 27.34M | 33.49M | 38.31M | 29.92M | 23.62M |
Gross Profit | 3.17M | 2.59M | -265K | 5.71M | 7.26M | 9.7M | 15.69M | 8.27M | 9.04M | 10.03M | 6.55M | 9.75M | -5.41M | -16.21M | -23.35M | -30.23M | -23.96M | -20.51M |
Operating Income | -144.24M | -139.7M | -134.82M | -119.47M | -111.59M | -102.09M | -93.46M | -90.75M | -82.58M | -73.22M | -66.62M | -62.17M | -61.44M | -56.87M | -48.64M | -42.25M | -33.58M | -28.52M |
Interest Income | 9.27M | 12.68M | 12.06M | 11.88M | 10.92M | 9.05M | 8M | 6.3M | 4.11M | 2.72M | 1.59M | 692K | 161K | 17K | 16K | 17K | 15K | 13K |
Pretax Income | -136.78M | -131.48M | -127.5M | -111.3M | -104.41M | -96.8M | -89.22M | -88.33M | -81.58M | -72.63M | -66.22M | -61.7M | -61.29M | -56.87M | -48.63M | -42.23M | -33.56M | -28.5M |
Net Income | -136.78M | -131.48M | -127.5M | -111.3M | -104.41M | -96.8M | -89.22M | -88.4M | -81.65M | -72.55M | -66.14M | -61.54M | -61.14M | -56.86M | -48.63M | -42.23M | -33.56M | -28.5M |
Selling & General & Admin | 32.26M | 30.93M | 29.56M | 27.15M | 25.63M | 24.39M | 25.07M | 26.33M | 25.35M | 23.63M | 20.35M | 18.66M | 17.8M | 15.72M | 13.83M | 12.02M | 9.62M | 8.01M |
Research & Development | 118.04M | 112.28M | 107.35M | 100.4M | 96.88M | 91.23M | 88.15M | 81.35M | 73.64M | 66.91M | 59.82M | 56.82M | 56M | 52.3M | 44.95M | 38.31M | 29.92M | 23.62M |
Other Expenses | 193K | 193K | 17K | n/a | n/a | n/a | n/a | 900K | 900K | 900K | 907K | 7K | 7K | 7K | n/a | n/a | n/a | n/a |
Operating Expenses | 150.49M | 143.41M | 136.93M | 127.55M | 122.51M | 115.62M | 113.23M | 107.68M | 98.99M | 90.53M | 80.17M | 75.48M | 73.8M | 68.02M | 58.78M | 50.33M | 39.54M | 31.63M |
Interest Expense | 1.73M | 3.37M | 3.65M | 3.72M | 3.75M | 3.76M | 3.76M | 3.88M | 3.1M | 2.13M | 1.18M | 201K | n/a | n/a | n/a | 3K | 3K | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.28M | -1.28M | -1.28M | -1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 109.47M | 144.12M | 137.64M | 128.83M | 123.79M | 116.9M | 114.51M | 107.68M | 98.99M | 90.53M | 80.17M | 75.48M | 73.8M | 68.02M | 58.78M | 50.33M | 39.54M | 31.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 74K | 74K | -75K | -82K | -158K | -161K | -17K | -16K | -20K | -18K | -16K |
Shares Outstanding (Basic) | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M | 24.94M |
Shares Outstanding (Diluted) | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M | 24.94M |
EPS (Basic) | -1.09 | -1.09 | -1.15 | -1.06 | -1.05 | -1.28 | -1.89 | -2.46 | -2.89 | -3 | -2.74 | -2.55 | -2.55 | -2.38 | -2.03 | -1.77 | -1.4 | -1.18 |
EPS (Diluted) | -1.09 | -1.09 | -1.15 | -1.06 | -1.05 | -1.28 | -1.89 | -2.46 | -2.89 | -3 | -2.74 | -2.55 | -2.55 | -2.38 | -2.03 | -1.77 | -1.4 | -1.18 |
EBITDA | -133.64M | -124.58M | -119.74M | -102.91M | -95.73M | -87.92M | -80.1M | -78.88M | -72.94M | -65.06M | -59.91M | -56.7M | -56.69M | -52.82M | -45.31M | -39.66M | -31.71M | -27.04M |
EBIT | -97.4M | -128.11M | -123.85M | -107.58M | -100.67M | -93.03M | -85.46M | -84.45M | -78.47M | -70.5M | -65.05M | -61.5M | -61.29M | -56.88M | -48.64M | -42.25M | -33.58M | -28.52M |
Depreciation & Amortization | 2.42M | 3.53M | 4.11M | 4.68M | 4.94M | 5.12M | 5.36M | 5.57M | 5.53M | 5.44M | 5.14M | 4.79M | 4.6M | 4.05M | 3.33M | 2.58M | 1.87M | 1.48M |